respiratory syncytial virus
Miguel Regueiro, MD, Picks His Favorite IBD Research From ACG 2024
Miguel Regueiro, MD, sat down with GEN to talk about some of his favorite studies focused on treating IBD.
NOVEMBER 19, 2024
FDA Grants New Indication for Abrysvo for At-Risk Adults From 18 to 59
The FDA granted a new indication for Pfizer’s Abrysvo RSV vaccine for younger adults whose chronic condition ...
OCTOBER 24, 2024
Patients With IBD at Higher Risk for RSV
Patients with inflammatory bowel disease are at increased risk for respiratory syncytial virus infection, according ...
JANUARY 4, 2024
Load more